These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34045624)

  • 1. Insights of antiparasitic activity of sodium diethyldithiocarbamate against different strains of Trypanosoma cruzi.
    de Freitas Oliveira JW; Torres TM; Moreno CJG; Amorim-Carmo B; Damasceno IZ; Soares AKMC; da Silva Barbosa J; Rocha HAO; Silva MS
    Sci Rep; 2021 May; 11(1):11200. PubMed ID: 34045624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Validation of Antiparasitic Activity of PLA-Nanoparticles of Sodium Diethyldithiocarbamate against
    de Freitas Oliveira JW; da Silva MFA; Damasceno IZ; Rocha HAO; da Silva Júnior AA; Silva MS
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335875
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
    Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
    Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance.
    Almeida-Silva J; Menezes DS; Fernandes JMP; Almeida MC; Vasco-Dos-Santos DR; Saraiva RM; Viçosa AL; Perez SAC; Andrade SG; Suarez-Fontes AM; Vannier-Santos MA
    Front Cell Infect Microbiol; 2022; 12():926699. PubMed ID: 35967878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A.
    Morais TR; Conserva GAA; Varela MT; Costa-Silva TA; Thevenard F; Ponci V; Fortuna A; Falcão AC; Tempone AG; Fernandes JPS; Lago JHG
    Sci Rep; 2020 Mar; 10(1):5467. PubMed ID: 32214193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
    Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into Chagas treatment based on the potential of bacteriocin AS-48.
    Martín-Escolano R; Cebrián R; Martín-Escolano J; Rosales MJ; Maqueda M; Sánchez-Moreno M; Marín C
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():1-8. PubMed ID: 30953804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanocidal activity of polysaccharide extract from Genipa americana leaves.
    Souza RODS; Sousa PL; Menezes RRPPB; Sampaio TL; Tessarolo LD; Silva FCO; Pereira MG; Martins AMC
    J Ethnopharmacol; 2018 Jan; 210():311-317. PubMed ID: 28887214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Trypanosoma cruzi activity of nicotinamide.
    Soares MB; Silva CV; Bastos TM; Guimarães ET; Figueira CP; Smirlis D; Azevedo WF
    Acta Trop; 2012 May; 122(2):224-9. PubMed ID: 22281243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiparasitic effect of (-)-α-bisabolol against Trypanosoma cruzi Y strain forms.
    de Menezes RRPPB; Sampaio TL; Lima DB; Sousa PL; de Azevedo IEP; Magalhães EP; Tessarolo LD; Marinho MM; Dos Santos RP; Martins AMC
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114860. PubMed ID: 31353066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aromatic imidazoline derived from chloroquinoline triggers cell cycle arrest and inhibits with high selectivity the Trypanosoma cruzi mammalian host-cells infection.
    Cuevas-Hernández RI; Girard RMBM; Krstulović L; Bajić M; Silber AM
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009994. PubMed ID: 34843481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammea type coumarins isolated from Calophyllum brasiliense induced apoptotic cell death of Trypanosoma cruzi through mitochondrial dysfunction, ROS production and cell cycle alterations.
    Rodríguez-Hernández KD; Martínez I; Reyes-Chilpa R; Espinoza B
    Bioorg Chem; 2020 Jul; 100():103894. PubMed ID: 32388434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
    da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
    Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of proline analogs as trypanocidal agents through the inhibition of a Trypanosoma cruzi proline transporter.
    Sayé M; Fargnoli L; Reigada C; Labadie GR; Pereira CA
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2913-2921. PubMed ID: 28844978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
    Engel JC; Ang KK; Chen S; Arkin MR; McKerrow JH; Doyle PS
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3326-34. PubMed ID: 20547819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Hydroxy-2-methylene-3-(4-nitrophenylpropanenitrile): A new highly active compound against epimastigote and trypomastigote form of Trypanosoma cruzi.
    Sandes JM; Borges AR; Junior CG; Silva FP; Carvalho GA; Rocha GB; Vasconcellos ML; Figueiredo RC
    Bioorg Chem; 2010 Oct; 38(5):190-5. PubMed ID: 20638707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms.
    Becerra MC; Guiñazú N; Hergert LY; Pellegrini A; Mazzieri MR; Gea S; Albesa I
    Exp Parasitol; 2012 May; 131(1):57-62. PubMed ID: 22425748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butenolides from Nectandra oppositifolia (Lauraceae) displayed anti-Trypanosoma cruzi activity via deregulation of mitochondria.
    Conserva GAA; da Costa-Silva TA; Amaral M; Antar GM; Neves BJ; Andrade CH; Tempone AG; Lago JHG
    Phytomedicine; 2019 Feb; 54():302-307. PubMed ID: 30668381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.